Catalent, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • September 29th, 2017 • Catalent, Inc. • Pharmaceutical preparations • New York
The offering of the Shares is being conducted in connection with the transactions contemplated by the Interest Purchase Agreement, dated September 18, 2017 (the “Acquisition Agreement”), by and among Catalent Pharma Solutions, Inc., a Delaware corporation and an indirect wholly owned subsidiary of the Company (the “Buyer”), Cook Pharmica LLC, an Indiana limited liability company (“Cook Pharmica”), Cook Group Incorporated, an Indiana corporation (the “Seller”) and, solely for purposes of Section 7.19 of the Acquisition Agreement, the Company, pursuant to which the Buyer will acquire 100% of the outstanding equity interests of Cook Pharmica (the “Acquisition”). The transactions contemplated in this Agreement and the Acquisition Agreement are collectively referred to herein as the “Transactions.”
